Quarterly Journal of Nuclear Medicine and Molecular Imaging

Aims & Scope

The Quarterly Journal of Nuclear Medicine and Molecular Imaging publishes scientific papers on clinical and experimental topics of nuclear medicine.

Manuscripts may be submitted in the form of editorials, original articles, review articles and special articles.

The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.4
2024	1.30

SJR (SCImago Journal Rank)

Year	Value
2024	0.417

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	66

Journal Rank

Year	Value
2024	13416

Journal Citation Indicator

Year	Value
2024	166

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Immunoscore and its introduction in clinical practice

  Citation: 73

  Authors: Jérôme, Anastasia

• Conventional and advanced magnetic resonance imaging in patients with high-grade glioma

  Citation: 72

  Authors: Whitney B., Garth

• CT radiomics and PET radiomics: ready for clinical implementation?

  Citation: 61

  Authors: Marta, Diem, Martin W., Matea, Nicolaus, Hubert S., Matthias, Stephanie

• Advances in radioguided surgery in oncology

  Citation: 42

  Authors: Renato A., Sergi, Gianpiero, Giuliano, Luisa F., Domenico, Francesco

• The LIPI score and inflammatory biomarkers for selection of patients with solid tumors treated with checkpoint inhibitors

  Citation: 39

  Authors: Jose C., Gonzalo, Elie, Laura

• Advances in oncological treatment: limitations of RECIST 1.1 criteria

  Citation: 39

  Authors: Serena, Marie, Caroline

• Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview

  Citation: 38

  Authors: Rubel, Shreya, Ashutosh, Weibo

• Machine learning for radiomics-based multimodality and multiparametric modeling

  Citation: 35

  Authors: Lise, Sarah, Mathieu, Issam

• European regulations for the introduction of novel radiopharmaceuticals in the clinical setting

  Citation: 29

  Authors: Clemens, Ivan, Marianne, Sergio

• Hybrid imaging of musculoskeletal infections

  Citation: 28

  Authors: Andor W., Napoleone, Marco, Giuseppe, Chiara, Elena, Mario, Luca M., Alberto

---